NASOPHARYNGEAL CANCINOMA (NPC)
Clinical trials for NASOPHARYNGEAL CANCINOMA (NPC) explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CANCINOMA (NPC) trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CANCINOMA (NPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo strategy aims to catch and remove leftover cancer after radiation
Disease control OngoingThis early-phase trial studies whether a combination of regular check-ups, scans, blood tests, and ultrasound can safely find and guide removal of remaining cancer in neck lymph nodes after standard radiation for advanced nasopharyngeal cancer. About 50 adults aged 18-70 with N3 …
Matched conditions: NASOPHARYNGEAL CANCINOMA (NPC)
Phase: PHASE1 • Sponsor: Guiquan Zhu • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New combo therapy tailors radiation for advanced nasopharyngeal cancer
Disease control OngoingThis phase II trial tests a personalized treatment for metastatic nasopharyngeal carcinoma. Patients first receive tislelizumab (immunotherapy) plus chemotherapy. Those who respond well may avoid or reduce radiotherapy, while others get targeted radiation. The study aims to see i…
Matched conditions: NASOPHARYNGEAL CANCINOMA (NPC)
Phase: NA • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a simple pill keep nasopharyngeal cancer away?
Disease control OngoingThis Phase III trial tests whether adding a low-dose chemotherapy pill (capecitabine) after standard chemoradiation helps prevent cancer from returning in people with high-risk nasopharyngeal cancer. About 252 participants with stage T1-2N1M0 disease and certain high-risk feature…
Matched conditions: NASOPHARYNGEAL CANCINOMA (NPC)
Phase: PHASE3 • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC